Language
中文
Manufacturing
PRODUCTION
CAPABILITIES
Plasmid, virus, and cell production
fully closed system from apheresis to final product infusion
Features
- Single-use customized closed system
- Minimal manipulation
- Rapid genetic modification
- Minimized risk of contamination
Suzhou GMP facility
Suzhou GMP facility
Total 63,000 sq.ft standalone manufacturing facility designed by an European company with rich experience in cell gene therapy CMO
Total 21,500 sq.ft GMP clean area: 5 functional areas
Annual production capacity: 12,000 universal samples, and 3,200 autologous FasTCAR™ samples
Supply for clinical development and early-stage commercialization
Reserved capacity for external partnership programs
5 acres of perspective commercial plant
63,000Sq.ft
standalone manufacturing facility
21,500Sq.ft
GMP clean area
12,000+
Universal samples
3,200+
Autologous FasTCAR™ samples
Shanghai R&D facility